Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Recurrent Wheezing in Infants
NCT02113072Phase 3Completed
- Sponsor
- Universidade Federal de Pernambuco
- Start
- Apr 2014
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in wheeze (2 arms), sponsored by Universidade Federal de Pernambuco. Primary endpoints: Recurrence of wheezing at 2 months and Cytokine levels (IL-10, IL-12, INF-gamma) at 2 months. Started Apr 2014; status: completed.
02
Conditions
wheeze
Beyond the preview
Go deeper on NCT02113072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113072.